学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies
被引:40
作者
:
Calvert, AH
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Newcastle, Sch Med, Dept Oncol, Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Univ Newcastle, Sch Med, Dept Oncol, Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Calvert, AH
[
1
]
Egorin, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Newcastle, Sch Med, Dept Oncol, Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Univ Newcastle, Sch Med, Dept Oncol, Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
Egorin, MJ
[
1
]
机构
:
[1]
Univ Newcastle, Sch Med, Dept Oncol, Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
来源
:
EUROPEAN JOURNAL OF CANCER
|
2002年
/ 38卷
/ 01期
关键词
:
D O I
:
10.1016/S0959-8049(01)00340-9
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:11 / 16
页数:6
相关论文
共 52 条
[1]
Ando M, 2000, CLIN CANCER RES, V6, P4733
[2]
Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing
Ando, Y
论文数:
0
引用数:
0
h-index:
0
机构:
NAGOYA UNIV, SCH MED, DEPT INTERNAL MED 1, SHOWA KU, NAGOYA, AICHI 466, JAPAN
Ando, Y
Minami, H
论文数:
0
引用数:
0
h-index:
0
机构:
NAGOYA UNIV, SCH MED, DEPT INTERNAL MED 1, SHOWA KU, NAGOYA, AICHI 466, JAPAN
Minami, H
Saka, H
论文数:
0
引用数:
0
h-index:
0
机构:
NAGOYA UNIV, SCH MED, DEPT INTERNAL MED 1, SHOWA KU, NAGOYA, AICHI 466, JAPAN
Saka, H
Ando, M
论文数:
0
引用数:
0
h-index:
0
机构:
NAGOYA UNIV, SCH MED, DEPT INTERNAL MED 1, SHOWA KU, NAGOYA, AICHI 466, JAPAN
Ando, M
Sakai, S
论文数:
0
引用数:
0
h-index:
0
机构:
NAGOYA UNIV, SCH MED, DEPT INTERNAL MED 1, SHOWA KU, NAGOYA, AICHI 466, JAPAN
Sakai, S
Shimokata, K
论文数:
0
引用数:
0
h-index:
0
机构:
NAGOYA UNIV, SCH MED, DEPT INTERNAL MED 1, SHOWA KU, NAGOYA, AICHI 466, JAPAN
Shimokata, K
[J].
BRITISH JOURNAL OF CANCER,
1997,
76
(08)
: 1067
-
1071
[3]
RANDOMIZED TRIAL OF ETOPOSIDE AND CISPLATIN VERSUS ETOPOSIDE AND CARBOPLATIN IN PATIENTS WITH GOOD-RISK GERM-CELL TUMORS - A MULTIINSTITUTIONAL STUDY
BAJORIN, DF
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
BAJORIN, DF
SAROSDY, MF
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
SAROSDY, MF
PFISTER, DG
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
PFISTER, DG
MAZUMDAR, M
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
MAZUMDAR, M
MOTZER, RJ
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
MOTZER, RJ
SCHER, HI
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
SCHER, HI
GELLER, NL
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
GELLER, NL
FAIR, WR
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
FAIR, WR
HERR, H
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
HERR, H
SOGANI, P
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
SOGANI, P
SHEINFELD, J
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
SHEINFELD, J
RUSSO, P
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
RUSSO, P
VLAMIS, V
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
VLAMIS, V
CAREY, R
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
CAREY, R
VOGELZANG, NJ
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
VOGELZANG, NJ
CRAWFORD, ED
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
CRAWFORD, ED
BOSL, GJ
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
BOSL, GJ
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1993,
11
(04)
: 598
-
606
[4]
Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer
Belani, CP
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Belani, CP
Kearns, CM
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Kearns, CM
Zuhowski, EG
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Zuhowski, EG
Erkmen, K
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Erkmen, K
Hiponia, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Hiponia, D
Zacharski, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Zacharski, D
Engstrom, C
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Engstrom, C
Ramanathan, RK
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Ramanathan, RK
Capozzoli, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Capozzoli, MJ
Aisner, J
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Aisner, J
Egorin, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Egorin, MJ
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1999,
17
(02)
: 676
-
684
[5]
CALVERT AH, 1995, SEMIN ONCOL, V22, P91
[6]
EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
CALVERT, AH
HARLAND, SJ
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
HARLAND, SJ
NEWELL, DR
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
NEWELL, DR
SIDDIK, ZH
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
SIDDIK, ZH
JONES, AC
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
JONES, AC
MCELWAIN, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
MCELWAIN, TJ
RAJU, S
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
RAJU, S
WILTSHAW, E
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
WILTSHAW, E
SMITH, IE
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
SMITH, IE
BAKER, JM
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
BAKER, JM
PECKHAM, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
PECKHAM, MJ
HARRAP, KR
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
HARRAP, KR
[J].
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1982,
9
(03)
: 140
-
147
[7]
CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
CALVERT, AH
NEWELL, DR
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
NEWELL, DR
GUMBRELL, LA
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
GUMBRELL, LA
OREILLY, S
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
OREILLY, S
BURNELL, M
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
BURNELL, M
BOXALL, FE
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
BOXALL, FE
SIDDIK, ZH
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
SIDDIK, ZH
JUDSON, IR
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
JUDSON, IR
GORE, ME
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
GORE, ME
WILTSHAW, E
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
WILTSHAW, E
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1989,
7
(11)
: 1748
-
1756
[8]
PHASE-I STUDIES WITH CARBOPLATIN AT THE ROYAL-MARSDEN-HOSPITAL
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
CALVERT, AH
HARLAND, SJ
论文数:
0
引用数:
0
h-index:
0
HARLAND, SJ
NEWELL, DR
论文数:
0
引用数:
0
h-index:
0
NEWELL, DR
SIDDIK, ZH
论文数:
0
引用数:
0
h-index:
0
SIDDIK, ZH
HARRAP, KR
论文数:
0
引用数:
0
h-index:
0
HARRAP, KR
[J].
CANCER TREATMENT REVIEWS,
1985,
12
: 51
-
57
[9]
Calvert AH, 1997, SEMIN ONCOL, V24, pS85
[10]
Calvert AH, 1999, SEMIN ONCOL, V26, P90
←
1
2
3
4
5
6
→
共 52 条
[1]
Ando M, 2000, CLIN CANCER RES, V6, P4733
[2]
Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing
Ando, Y
论文数:
0
引用数:
0
h-index:
0
机构:
NAGOYA UNIV, SCH MED, DEPT INTERNAL MED 1, SHOWA KU, NAGOYA, AICHI 466, JAPAN
Ando, Y
Minami, H
论文数:
0
引用数:
0
h-index:
0
机构:
NAGOYA UNIV, SCH MED, DEPT INTERNAL MED 1, SHOWA KU, NAGOYA, AICHI 466, JAPAN
Minami, H
Saka, H
论文数:
0
引用数:
0
h-index:
0
机构:
NAGOYA UNIV, SCH MED, DEPT INTERNAL MED 1, SHOWA KU, NAGOYA, AICHI 466, JAPAN
Saka, H
Ando, M
论文数:
0
引用数:
0
h-index:
0
机构:
NAGOYA UNIV, SCH MED, DEPT INTERNAL MED 1, SHOWA KU, NAGOYA, AICHI 466, JAPAN
Ando, M
Sakai, S
论文数:
0
引用数:
0
h-index:
0
机构:
NAGOYA UNIV, SCH MED, DEPT INTERNAL MED 1, SHOWA KU, NAGOYA, AICHI 466, JAPAN
Sakai, S
Shimokata, K
论文数:
0
引用数:
0
h-index:
0
机构:
NAGOYA UNIV, SCH MED, DEPT INTERNAL MED 1, SHOWA KU, NAGOYA, AICHI 466, JAPAN
Shimokata, K
[J].
BRITISH JOURNAL OF CANCER,
1997,
76
(08)
: 1067
-
1071
[3]
RANDOMIZED TRIAL OF ETOPOSIDE AND CISPLATIN VERSUS ETOPOSIDE AND CARBOPLATIN IN PATIENTS WITH GOOD-RISK GERM-CELL TUMORS - A MULTIINSTITUTIONAL STUDY
BAJORIN, DF
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
BAJORIN, DF
SAROSDY, MF
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
SAROSDY, MF
PFISTER, DG
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
PFISTER, DG
MAZUMDAR, M
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
MAZUMDAR, M
MOTZER, RJ
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
MOTZER, RJ
SCHER, HI
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
SCHER, HI
GELLER, NL
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
GELLER, NL
FAIR, WR
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
FAIR, WR
HERR, H
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
HERR, H
SOGANI, P
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
SOGANI, P
SHEINFELD, J
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
SHEINFELD, J
RUSSO, P
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
RUSSO, P
VLAMIS, V
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
VLAMIS, V
CAREY, R
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
CAREY, R
VOGELZANG, NJ
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
VOGELZANG, NJ
CRAWFORD, ED
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
CRAWFORD, ED
BOSL, GJ
论文数:
0
引用数:
0
h-index:
0
机构:
SW ONCOL GRP, SAN ANTONIO, TX USA
BOSL, GJ
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1993,
11
(04)
: 598
-
606
[4]
Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer
Belani, CP
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Belani, CP
Kearns, CM
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Kearns, CM
Zuhowski, EG
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Zuhowski, EG
Erkmen, K
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Erkmen, K
Hiponia, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Hiponia, D
Zacharski, D
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Zacharski, D
Engstrom, C
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Engstrom, C
Ramanathan, RK
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Ramanathan, RK
Capozzoli, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Capozzoli, MJ
Aisner, J
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Aisner, J
Egorin, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Pittsburgh, Inst Canc, Dept Med, Div Med Oncol, Pittsburgh, PA 15213 USA
Egorin, MJ
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1999,
17
(02)
: 676
-
684
[5]
CALVERT AH, 1995, SEMIN ONCOL, V22, P91
[6]
EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
CALVERT, AH
HARLAND, SJ
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
HARLAND, SJ
NEWELL, DR
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
NEWELL, DR
SIDDIK, ZH
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
SIDDIK, ZH
JONES, AC
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
JONES, AC
MCELWAIN, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
MCELWAIN, TJ
RAJU, S
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
RAJU, S
WILTSHAW, E
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
WILTSHAW, E
SMITH, IE
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
SMITH, IE
BAKER, JM
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
BAKER, JM
PECKHAM, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
PECKHAM, MJ
HARRAP, KR
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,DIV MED,SUTTON SM2 5PT,SURREY,ENGLAND
HARRAP, KR
[J].
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1982,
9
(03)
: 140
-
147
[7]
CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
CALVERT, AH
NEWELL, DR
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
NEWELL, DR
GUMBRELL, LA
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
GUMBRELL, LA
OREILLY, S
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
OREILLY, S
BURNELL, M
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
BURNELL, M
BOXALL, FE
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
BOXALL, FE
SIDDIK, ZH
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
SIDDIK, ZH
JUDSON, IR
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
JUDSON, IR
GORE, ME
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
GORE, ME
WILTSHAW, E
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP, SUTTON, SURREY, ENGLAND
WILTSHAW, E
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1989,
7
(11)
: 1748
-
1756
[8]
PHASE-I STUDIES WITH CARBOPLATIN AT THE ROYAL-MARSDEN-HOSPITAL
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
CALVERT, AH
HARLAND, SJ
论文数:
0
引用数:
0
h-index:
0
HARLAND, SJ
NEWELL, DR
论文数:
0
引用数:
0
h-index:
0
NEWELL, DR
SIDDIK, ZH
论文数:
0
引用数:
0
h-index:
0
SIDDIK, ZH
HARRAP, KR
论文数:
0
引用数:
0
h-index:
0
HARRAP, KR
[J].
CANCER TREATMENT REVIEWS,
1985,
12
: 51
-
57
[9]
Calvert AH, 1997, SEMIN ONCOL, V24, pS85
[10]
Calvert AH, 1999, SEMIN ONCOL, V26, P90
←
1
2
3
4
5
6
→